The Future Focus™ is a MattsonJack DaVinci series developed by The Mattson Jack Group (MJG) and offered through BioSeeker Group. MJG offers clients comprehensive, integrated and future-focused assessments of the impact of novel agents and changes in selected therapeutic areas in the United States and around the world. Each report identifies key technologies and products that will have a mid- to long-term commercial effect on a given market, quantifies future treatment trends and projects the competitive market based on future alternative scenarios. Future Focus™: Myelodysplastic Syndromes (U.S.)™ — Examines the current and future U.S. Myelodysplastic Syndromes market Future Focus™: GI Stromal Tumor (U.S.)™ — Examines the current and future U.S. GIST market

Free Bonus Reports

When you invest in any of the two above reports you may pick any 10 Cancer Highlights reports from this list free of charge.

Value: €19,500 EUR

About Future Focus reports:

• provide strategic insights and recommendations on implications identified in future scenarios quantify the potential future for selected therapeutic areas
• incorporate primary fieldwork conducted at major clinical conferences with the latest clinical data available
• assess key issues, such as changes in patient segmentation, use of pharmacoeconomics, impact of providers and reimbursement drivers
• develop potential alternative futures using DaVinci's scenarios methodology that focuses on emerging technologies and potential changes in clinical management